Johan M. Spoor - Chief Executive Officer, Director at Perspective Therapeutics, Inc.

Issuer-level insider activity

Role: Chief Executive Officer, Director
Issuer ticker: CATX on NYSE
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Johan M. Spoor since 05 Aug 2025

Reported holdings for Johan M. Spoor in Perspective Therapeutics, Inc.

Form 4 holding Chief Executive Officer, Director

Perspective Therapeutics, Inc.

Security class: Common Stock
Shares / value: 59,383
Estimated value: $133,143
Report date: 28 Mar 2025
Price: $2.24
Ownership: Direct

Form 4 holding Chief Executive Officer, Director

Perspective Therapeutics, Inc.

Security class: Common Stock
Shares / value: 12,600
Estimated value: $27,012
Report date: 28 Mar 2025
Price: $2.14
Ownership: By IRA of Spouse

Form 4 holding Chief Executive Officer, Director

Perspective Therapeutics, Inc.

Security class: Common Stock
Shares / value: 5,400
Estimated value: $11,577
Report date: 28 Mar 2025
Price: $2.14
Ownership: By IRA of Reporting Person

Form 4 holding Chief Executive Officer, Director

Perspective Therapeutics, Inc.

Security class: Common Stock
Shares / value: 4,650
Estimated value: $10,288
Report date: 28 Mar 2025
Price: $2.21
Ownership: By Child #1

Form 4 holding Chief Executive Officer, Director

Perspective Therapeutics, Inc.

Security class: Common Stock
Shares / value: 4,650
Estimated value: $9,969
Report date: 28 Mar 2025
Price: $2.14
Ownership: By Child #2

Form 4 holding Chief Executive Officer, Director

Perspective Therapeutics, Inc.

Security class: Common Stock
Shares / value: 1,000
Estimated value: $2,144
Report date: 28 Mar 2025
Price: $2.14
Ownership: By Spouse

Form 4 holding Chief Executive Officer, Director

Perspective Therapeutics, Inc.

Security class: Stock option (right to buy)
Shares / value: 735,000
Estimated value
Report date: 02 Mar 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for Johan M. Spoor in Perspective Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .